The Orf virus E3L homologue is able to complement deletion of the vaccinia virus E3L gene in vitro but not in vivo

Virology

Volumn 314, Issue 1, 2003, Pages 305-314

  Vijaysri, Sangeetha ^a   Talasela, Latha ^a   Mercer, Andrew A ^b   Mcinnes, Colin J ^c   Jacobs, Bertram L ^a   Langland, Jeffrey O ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c MOREDUN RESEARCH INSTITUTE   (United Kingdom)

Author keywords

dsRNA binding protein; E3L; Orf virus; OV20.0L; Vaccinia; Virulence

Indexed keywords

GENE PRODUCT; INTERFERON; RECOMBINANT PROTEIN; RNA BINDING PROTEIN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE MONITORING; COMPARATIVE GENE MAPPING; CONTROLLED STUDY; E3L GENE; EXPERIMENTAL INFECTION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC COMPLEMENTATION; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; LD 50; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; POXVIRUS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RNA BINDING; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VIRAL GENETICS; VIRUS GENE; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS PATHOGENESIS;

ORF VIRUS; PARAPOXVIRUS; VACCINIA VIRUS;

EID: 0141568807     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00433-1     Document Type: Article

References (47)

1. Bass B.L. RNA editing and hypermutation by adenosine deamination [Review]. Trends Biochem Sci. 22:1997;157-162.
2. Beattie E., Denzler K.L., Tartaglia J., Perkus M.E., Paolette E., Jacobs B.L. Reversal of the IFN sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69:1995;499-505.
3. Beattie E., Kauffman E.B., Martinez H., Perkus M.E., Jacobs B.L., Paoletti E., Tartaglia J. Host-range restriction of vaccinia virus E3L-specific deletion mutants. Virus Genes. 12:1996;89-94.
4. Bloom D.C., Edwards K.M., Hagar C., Moyer R.W. Identification and characterization of two non-essential regions of the rabbit poxvirus genome involved in virulence. J. Virol. 65:1991;1530-1542.
5. Brandt T.A., Jacobs B.L. Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model. J Virol. 75:2001;850-862.
6. Brown B.A. II, Lowenhaupt K., Wilbert C.M., Hanlon E.B., Rich A. The Za somain of the editing enzyme dsRNA adenosine deaminase binds left-handed Z-RNA as well as Z-DNA. Proc. Natl. Acad. Sci. USA. 97:2000;13532-13536.
7. Bycroft M., Grunert S., Murzin A.G., Proctor M., St Johnson D. NMR solution structure of dsRNA binding domain from Drosophila Staufen protein reveals homology to the N-terminal domain of ribosomal protein S5. EMBO J. 14:1995;3563-3571.
8. Cattaneo R. Biased (A → I) hypermutation of animal RNA virus genomes [Review]. Curr. Opin. Genet. Dev. 4:1994;895-900.
9. Cattaneo R., Billeter M.A. Mutations and A/I hypermutations in measles virus persistent infections [Review]. Curr. Top. Microbiol. Immunol. 176:1992;63-74.
10. Chang H.W., Jacobs B.L. Identification of the conserved motif that is necessary for binding of the VV E3L gene products to dsRNA. Virology. 194:1993;537-547.
11. Chang H.W., Uribe L.H., Jacobs B.L. Rescue of vaccinia virus lacking the E3L gene by mutants of E3L. J. Virol. 69:1995;6605-6608.
12. Falkner F.G., Moss B. Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. J. Virol. 62:1988;1849-1854.
13. Fenner F. Risks and benefits of vaccinia viruses in worldwide eradication campaign. Res. Virol. 140:1989;465-466. discussion 487-491.
14. Gurich E.C., Villesova L.S. Vaccinia virus in post-vaccinial encephalitis. Acta Virol. 27:1983;154-159.
15. Haig D.M., McInnes C.J., Thomson J., Wood A., Bunyan K., Mercer A. The orf virus OV20.0L gene product is involved in interferon resistance and inhibits an interferon-inducible double-stranded RNA-dependent kinase. Immunology. 93:1998;335-340.
16. Haig D.M., Mercer A.A. Ovine diseases. Orf. Vet. Res. 29:1998;311-326. [Review].
17. Herbert A., Rich A. The biology of left-handed Z-DNA. J. Biol. Chem. 271:1996;11595-11598.
18. Ho C.K., Shuman S. Mutational analysis of the vaccinia virus E3 protein defines amino acid residues involved in E3 binding to double-stranded RNA. J. Virol. 70:1996;2611-2614.
19. Ho C.K., Shuman S. Physical and functional characterization of the double-stranded RNA binding protein encoded by the vaccinia virus E3 gene. Virology. 217:1996;272-284.
20. Jacobs B.L., Langland J.O. When two strands are better than one the mediators and modulators of the cellular responses to double-stranded RNA . Virology. 219:1996;339-349.
21. Johnston D., Brown N.H., Gall J.G., Jantsch M. A conserved double-stranded RNA-binding domain. Proc. Natl. Acad. Sci. USA. 89:1992;10979-10983.
22. Kaplan C. Vaccinia virus a suitable vehicle for recombinant vaccines? Arch. Virol. 106:1989;127-139.
23. Keller W., Wolf J., Gerber A. Editing of mRNA processing and of t RNAs by adenosine to inosine conversion. FEBS Lett. 452:1999;71-76.
24. Kharrat A., Macias M.J., Gibson T.J., Nilges M., Pastore A. Structure of the dsRNA binding domain of E. coli RNase III. EMBO J. 14:1995;3572-3584.
25. Kibler K.V., Shors T., Perkins K.B., Zeman C.C., Banaszak M.P., Beisterfeildt J., Langland J.O., Jacobs B.L. Double stranded RNA is a trigger for apoptosis in VV infected cells. J. Virol. 70:1997;1992-2003.
26. Langland J.O., Pettiford S.M., Jiang B., Jacobs B.L. Products of the porcine NSP3 gene binds specifically to double-stranded RNA and inhibit activation of the interferon-induced protein kinase, PKR. J. Virol. 68:1994;3821-3829.
27. Liu L.F., Wang J.C. Supercoiling of the DNA template during transcription. Proc. Natl. Acad. Sci. USA. 84:1987;7024-7027.
28. McInnes C.J., Wood A.R., Mercer A.A. Orf virus encodes a homolog of the vaccinia virus interferon-resistance gene E3L. Virus Genes. 17:1998;107-115.
29. Moss B. Genetically engineered poxviruses for recombinant gene expression, vaccination and safety. Proc. Natl. Acad. Sci. USA. 93:1996;11341-11348.
30. Nanduri S., Capick B.W., Yang Y., Williams B.R.G., Qin J. Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. EMBO J. 17:1998;5458-5465.
31. Patel R.C., Stanton P., Sen G.C. Specific mutations near the amino terminus of double-stranded RNA-dependent protein kinase (PKR) differentially affect its double-stranded RNA binding and oligomerization properties. J. Biol. Chem. 271:1996;25657-25663.
32. Pincus S., Tartaglia J., Paoletti E. Poxvirus-based vectors as vaccine candidates. Biologicals. 23:1995;159-164.
33. Ramos A., Grunert S., Adams J., Micklem D.R., Proctor M.R., Freund S., Bycroft M., St Johnson D., Varani G. RNA recognition by a Staufen double-stranded RNA-binding domain. EMBO J. 19:2000;997-1009.
34. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hygiene. 27:1938;493-497.
35. Rivas C., Gil J., Melkova Z., Esteban M., Diaz-Guerra M. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzymes. Virology. 243:1998;406-414.
36. Robinson A.J., Balassu T.C. Contagious pustular dermatitis (orf). Vet. Bull. 1:1981;771-782.
37. Romano P.R., Zhang F., Tan S.L., Garcia-Barrio M.T., Katze M.G., Dever T.E., Hinnebusch A.G. Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3 role of complex formation and the E3 N-terminal domain . Mol. Cell. Biol. 12:1998;7304-7316.
38. Ryter J.M., Schultz S.C. Molecular basis of double-stranded RNA-protein interactions structure of a dsRNA-binding domain complexed with dsRNA . EMBO J. 17:1998;7505-7513.
39. Schade M., Turner C.J., Lowenhaupt K., Rich A., Herbert A. Structure-function analysis of the Z-DNA-binding domain Zα of dsRNA adenosine deaminase type I reveals similarity to the (α+β) family of helix-turn-helix proteins. EMBO J. 18:1999;470-479.
40. Schwartz T., Rould M.A., Lowenhaupt K., Herbert A., Rich A. Crystal structure of the Zα domain of human editing enzyme ADAR1 bound to left handed Z-DNA. Science. 284:1999;1841-1845.
41. Seeburg P.H., Higuchi M., Sprengel R. RNA editing of brain glutamate receptor channels mechanism and physiology . Brain Res. Rev. 26:1998;217-229.
42. Sen G.C., Lengyel P. The interferon system a bird's eye view of its biochemistry . J. Biol. Chem. 267:1992;5017-5020.
43. Shors S.T., Beattie E., Paoletti E., Tartaglia J., Jacobs B.L. Role of the vaccinia virus E3L and K3L gene products in rescue of VSV and EMCV from the effects of IFN-alpha. J. Interferon Cytokine Res. 9:1998;721-729.
44. Shors T., Jacobs B.L. Complementation of deletion of the vaccinia virus E3L gene by E. coli RNase III gene. Virology. 227:1997;1-11.
45. Shors T., Kibler K.V., Perkins K.B., Seidler-Wulff R., Banaszak M.P., Jacobs B.L. Complementation of the vaccinia virus deleted of the E3L gene by mutants of E3L. Virology. 239:1997;269-272.
46. Smith G.L., Symons J.A., Alcami A. Poxviruses interfering with interferon . Semin. Virol. 8:1998;409-418.
47. Yuwen H., Cox J.H., Yewdell J.W., Bennink J.R., Moss B. Nuclear localization of a double-stranded RNA binding protein encoded by the vaccinia virus E3L gene. Virology. 195:1993;732-744.